Pharma Marketing Blog talks about Rozerem’s big marketing push, and wonders how such ludicrous displays passes FDA regulation:
BTW, how are little promos like this on medical conference sites sponsored by CME providers like M|C Communications — host of the Pri-Med Conference — regulated by the FDA? For example, the benefit statement above is not balanced by risk information, nor is there any link on this page to the package insert or to the Rozerem Web site where the physician can see the PI.Perhaps M|C Communications will claim that they wrote the promo, not Takeda and the FDA has no jurisdiction over what it can say. Yeah, right!
Similar Posts:
- Why don’t drug companies use Twitter?
- How to make industry influence transparent in continuing medical education
- Communication with the patient may not be helped by time
KevinMD.com on Facebook
Comments on this entry are closed.